Axon Enterprise, Inc $AXON Holdings Raised by CIBC Private Wealth Group LLC

CIBC Private Wealth Group LLC increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 26.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 186,538 shares of the biotechnology company’s stock after purchasing an additional 38,966 shares during the quarter. CIBC Private Wealth Group LLC owned 0.24% of Axon Enterprise worth $133,867,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in AXON. CIBC Bancorp USA Inc. acquired a new stake in shares of Axon Enterprise during the third quarter worth $9,718,000. Captrust Financial Advisors lifted its position in shares of Axon Enterprise by 19.4% in the 3rd quarter. Captrust Financial Advisors now owns 15,666 shares of the biotechnology company’s stock worth $11,242,000 after buying an additional 2,545 shares during the last quarter. Coldstream Capital Management Inc. boosted its holdings in shares of Axon Enterprise by 0.8% in the 3rd quarter. Coldstream Capital Management Inc. now owns 6,922 shares of the biotechnology company’s stock valued at $4,968,000 after buying an additional 57 shares during the period. Danske Bank A S acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at about $39,628,000. Finally, GM Advisory Group LLC grew its position in shares of Axon Enterprise by 2.1% during the 3rd quarter. GM Advisory Group LLC now owns 2,355 shares of the biotechnology company’s stock valued at $1,690,000 after buying an additional 48 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

AXON has been the topic of several research reports. UBS Group dropped their price objective on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 25th. Northcoast Research upgraded Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price for the company in a research note on Tuesday, January 6th. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Needham & Company LLC dropped their price target on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a research report on Friday, February 20th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Monday, December 29th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $762.93.

Insider Activity at Axon Enterprise

In other news, insider Isaiah Fields sold 2,000 shares of the stock in a transaction on Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the transaction, the insider owned 55,588 shares of the company’s stock, valued at approximately $29,740,135.88. This represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Jennifer H. Mak sold 1,500 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total value of $860,175.00. Following the completion of the transaction, the chief accounting officer directly owned 12,240 shares of the company’s stock, valued at approximately $7,019,028. The trade was a 10.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 24,634 shares of company stock worth $13,803,095 in the last three months. 5.70% of the stock is owned by company insiders.

Axon Enterprise Price Performance

NASDAQ AXON opened at $506.57 on Wednesday. Axon Enterprise, Inc has a 52 week low of $396.41 and a 52 week high of $885.91. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. The stock has a market cap of $40.73 billion, a price-to-earnings ratio of 333.27, a price-to-earnings-growth ratio of 10.45 and a beta of 1.46. The company has a 50-day moving average price of $526.65 and a two-hundred day moving average price of $604.44.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The company had revenue of $796.72 million for the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business’s revenue for the quarter was up 38.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.08 earnings per share. Analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.